Amylyx Pharmaceuticals Stock Forecast

Stock Price Forecast

The 4 analysts with 12-month price forecasts for Amylyx Pharmaceuticals stock have an average target of 7.50, with a low estimate of 3.00 and a high estimate of 12. The average target predicts an increase of 111.21% from the current stock price of 3.55.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$3.00	$7.50	$11	$12
Change	-15.51%	+111.21%	+209.78%	+237.94%

Analyst Ratings

The average analyst rating for Amylyx Pharmaceuticals stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	1
Buy	0	1	1	1	1	1
Hold	5	4	4	4	4	2
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	7	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+237.94%	Mar 5, 2025
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $12	Strong Buy	Reiterates	$12	+237.94%	Dec 5, 2024
Joel Beatty Baird	Baird	Hold → Buy Upgrades $3 → $11	Hold → Buy	Upgrades	$3 → $11	+209.78%	Nov 18, 2024
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $8 → $12	Strong Buy	Maintains	$8 → $12	+237.94%	Nov 8, 2024
Andrew Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $8	Strong Buy	Reiterates	$8	+125.29%	Oct 18, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 87.37M

Revenue Next Year

328.95K

EPS This Year

-2.05

from -4.43

EPS Next Year

-1.92

from -2.05

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	650.00K	285.00K	22.23M	380.79M	87.37M	-	328.95K	6.46M
Revenue Growth	-54.42%	-56.15%	7,700.00%	1,612.94%	-77.05%	-	-	1,863.52%
EPS	-6.96	-13.35	-3.39	0.70	-4.43	-2.05	-1.92	-1.89
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	7	6	6

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	n/a	677,250	13.3M
Avg	n/a	328,950	6.5M
Low	n/a	n/a	n/a

Revenue Growth

Revenue Growth	2025	2026	2027
High	-	-	3,942.3%
Avg	-	-	1,863.5%
Low	-	-	-

EPS Forecast

EPS	2025	2026	2027
High	-1.85	-1.83	-1.67
Avg	-2.05	-1.92	-1.89
Low	-2.21	-2.12	-2.22

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.